Literature DB >> 22572558

Validation of the English version of the Health-Related Quality of Life for Drug Abusers (HRQoLDA) test.

Carlos Zubaran1, Rishi Sud, Jonathan Emerson, Elham Zolfaghari, Katia Foresti, Oscar Lozano.   

Abstract

BACKGROUND: The Health-Related Quality of Life for Drug Abusers (HRQoLDA) test was designed to specifically evaluate quality of life among substance users. In this study, the validity and reliability of the English version of the HRQoLDA test are reported for the first time.
METHODS: A sample of 121 participants from inpatient and outpatient treatment facilities completed the HRQoLDA test.
RESULTS: The mean HRQoLDA score was 45.9 (SD = 16.9), while the overall Cronbach's alpha coefficient was 0.905. The factorial analysis of the HRQoLDA test revealed a unidimensional structure. Convergent validity analyses demonstrated significant correlations between the HRQoLDA test scores and the scores of the World Health Organization Quality of Life Assessment-Bref Questionnaire in different dimensions.
CONCLUSION: The results revealed that the HRQoLDA was successfully adapted to English. The HRQoLDA is a reliable research instrument for evaluating quality of life of substance users.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2012        PMID: 22572558     DOI: 10.1159/000337213

Source DB:  PubMed          Journal:  Eur Addict Res        ISSN: 1022-6877            Impact factor:   3.015


  2 in total

1.  Psychometrics of the Short Form 36 Health Survey version 2 (SF-36v2) and the Quality of Life Scale for Drug Addicts (QOL-DAv2.0) in Chinese mainland patients with methadone maintenance treatment.

Authors:  Kaina Zhou; Guihua Zhuang; Hongmei Zhang; Peifeng Liang; Juan Yin; Lingling Kou; Mengmeng Hao; Lijuan You
Journal:  PLoS One       Date:  2013-11-20       Impact factor: 3.240

2.  Comparison and concordance of health-related quality of life tests among substance users.

Authors:  Antonio J Rojas; Oscar Lozano; Katia Foresti; Elham Zolfaghari; Carlos Zubaran
Journal:  Health Qual Life Outcomes       Date:  2015-11-19       Impact factor: 3.186

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.